the clinical significance of surface markers was investigated in 145 cases of acute myeloid ( aml ) or undifferentiated leukaemia ( aul ) , using a panel of six monoclonal antibodies directed to nhl-30.5 antigen ( expressed on poorly differentiated myeloid cells ) , cd13 , cd14 , cd15 , cd33 and cd34 antigens .
C0024305
nhl
C0887899
myeloid cells